Publication: Once BCG Unresponsive, Always BCG Unresponsive: An Open Letter to the FDA to Enhance Recruitment into Clinical Trials in Bladder Cancer
Loading...
Open/View Files
Date
2017
Published Version
Journal Title
Journal ISSN
Volume Title
Publisher
IOS Press
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
Kamat, Ashish M., Seth Lerner, Peter Black, Joaquim Bellmunt, Colin Dinney, Noah M. Hahn, Michael O’Donnell, and Diane Z. Quale. 2017. “Once BCG Unresponsive, Always BCG Unresponsive: An Open Letter to the FDA to Enhance Recruitment into Clinical Trials in Bladder Cancer.” Bladder Cancer (Amsterdam, Netherlands) 3 (3): 145-146. doi:10.3233/BLC-170118. http://dx.doi.org/10.3233/BLC-170118.
Abstract
Description
Other Available Sources
Research Data
Keywords
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service